Alnylam Pharmaceuticals
ALNY
#603
Rank
C$56.63 B
Marketcap
C$424.49
Share price
0.70%
Change (1 day)
29.23%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company